Related Experiment Video
Updated: Feb 7, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
Zaril H Zakaria1,2, Alan Y Y Fong3,4,5, Raj K S Badhan6,7
1Ministry of Health Malaysia, Block E1, E3, E6, E7 & E10, Parcel E, Federal Government Administration Centre, Putrajaya 62590, Malaysia. zakariz1@aston.ac.uk.
Insights
Pharmacogenetic differences in Malaysians affect clopidogrel metabolism, impacting cardiovascular event prevention. A high-dose strategy partially restored therapeutic clopi-H4 levels in poor metabolizers.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in Malaysia, with clopidogrel used for secondary prevention.
- Clopidogrel efficacy depends on its active metabolite, clopi-H4, influenced by CYP2C19 enzyme activity.
- CYP2C19 genetic polymorphisms are prevalent in the Malaysian population, potentially causing therapeutic variability.
Purpose of the Study:
- To investigate the impact of inter-ethnicity pharmacogenetic variability on clopi-H4 plasma concentrations in Malaysians.
- To assess the effectiveness of different CYP2C19 genotypes on clopidogrel's therapeutic efficacy.
- To evaluate pharmacokinetic (PK) modeling for optimizing clopidogrel dosing strategies.
Main Methods:
- Pharmacokinetic (PK) modeling was employed to analyze clopi-H4 plasma concentrations.
- Comparison of clopi-H4 Cmax between extensive (EM) and poor metabolizer (PM) phenotypes across Malay and Malaysian Chinese groups.
- Evaluation of a high-dose clopidogrel strategy (600 mg loading, 150 mg maintenance) in PM individuals.
Main Results:
- A statistically significant difference (P < 0.001) in clopi-H4 Cmax was observed between EM and PM phenotypes in both ethnic groups.
- A substantial number of PM individuals had sub-therapeutic peak clopi-H4 concentrations.
- The high-dose strategy increased the proportion of subjects achieving minimum therapeutic clopi-H4 levels by approximately 50%.
Conclusions:
- Inter-ethnicity CYP2C19 variability significantly impacts clopidogrel metabolism and therapeutic concentration attainment in Malaysia.
- A high-dose clopidogrel regimen can partially overcome the reduced efficacy associated with CYP2C19 poor metabolizer status.
- Personalized dosing strategies based on pharmacogenetics are crucial for optimizing clopidogrel therapy in diverse Malaysian populations.
Abstract:
Malaysia is a multi-ethnic society whereby the impact of pharmacogenetic differences between ethnic groups may contribute significantly to variability in clinical therapy. One of the leading causes of mortality in Malaysia is cardiovascular disease (CVD), which accounts for up to 26% of all hospital deaths annually. Clopidogrel is used as an adjunct treatment in the secondary prevention of cardiovascular events. CYP2C19 plays an integral part in the metabolism of clopidogrel to the active metabolite clopi-H4. However, CYP2C19 genetic polymorphism, prominent in Malaysians, could influence target clopi-H4 plasma concentrations for clinical efficacy. This study addresses how inter-ethnicity variability within the Malaysian population impacts the attainment of clopi-H4 target plasma concentration under different CYP2C19 polymorphisms through pharmacokinetic (PK) modelling. We illustrated a statistically significant difference (P < 0.001) in the clopi-H4 Cmax between the extensive metabolisers (EM) and poor metabolisers (PM) phenotypes with either Malay or Malaysian Chinese population groups. Furthermore, the number of PM individuals with peak clopi-H4 concentrations below the minimum therapeutic level was partially recovered using a high-dose strategy (600 mg loading dose followed by a 150 mg maintenance dose), which resulted in an approximate 50% increase in subjects attaining the minimum clopi-H4 plasma concentration for a therapeutic effect.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Ethnic Identity within a Larger Culture
Conservation of Small Populations
What is Population Genetics?
Population Growth
Impact of Groups on Groups

